查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451034

2024-2032 年按类型（品牌药物、仿製药）、产品（定量吸入器、干粉吸入器）和地区分類的数位剂量吸入器市场报告

Digital Dose Inhaler Market Report by Type (Branded Medication, Generics Medication), Product (Metered Dose Inhaler, Dry Powder Inhaler), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球数位剂量吸入器市场规模达到33亿美元。展望未来， IMARC Group预计到2032年市场规模将达到101亿美元，2024-2032年复合年增长率（CAGR）为12.7%。对慢性呼吸道疾病管理的日益关注、即时调整的技术进步以及哮喘和慢性阻塞性肺病 (COPD) 等慢性呼吸道疾病 (CRD) 患病率的增加是推动市场的一些主要因素。

数位剂量吸入器 (DDI) 用于向患有气喘或慢性阻塞性肺病 (COPD) 等呼吸系统疾病的患者输送药物。它包括内建感测器和电子功能，可以记录给药时间和剂量。它有助于确保遵守规定的治疗常规，并更好地了解患者的疾病和药物的有效性。由于它向用户提供反馈并帮助他们纠正技术，全球对 DDI 的需求正在不断增长。

目前，DDI 的采用越来越多，因为它们在药物传输方面提供了更高的便利性和有效性，正在推动市场的成长。除此之外，患者对高效、有效的吸入装置的需求不断增长，这提供了积极的市场前景。与此一致的是，由于老年人更容易出现呼吸系统问题，DDI 越来越多地被老年人采用，这正在推动市场的成长。除此之外，DDI 的使用不断增加，因为它们使治疗更加透明且可能更有效，正在促进市场成长。此外，将人工智慧 (AI) 整合到 DDI 中可以加强对药物使用情况的监控并向患者提供即时回馈，这正在加强市场的成长。此外，个人对个人化药物的日益关注正在支持市场的成长。

数位剂量吸入器市场趋势/驱动因素：

慢性呼吸道疾病盛行率不断上升

气喘和慢性阻塞性肺病（COPD）等慢性呼吸道疾病（CRD）在全球人群中的盛行率不断上升，推动了市场的成长。此外，需要管理呼吸系统疾病的个体对增强药物传递系统的需求也在增加。除此之外，DDI 透过确保准确的剂量并向患者和医疗保健提供者提供使用回馈来提供现代解决方案，这提供了积极的市场前景。据此，收集的资料有助于个人化治疗计划、提高药物治疗的依从性，并有可能减少与 CRD 相关的住院治疗。

即时调整的技术进步

各家公司不断改进其 DDI，为患者提供更好的照护和满意度。它们为医疗保健提供者提供剂量计数、依从性监测和资料传输等功能。与此一致的是，这些功能促进了更好的疾病管理，允许即时调整治疗计划，并确保患者有效遵守其用药时间表，这提供了良好的市场前景。除此之外，DDI 中的技术可以向患者提供有关吸入技术的即时回馈，这对于治疗的有效性至关重要。因此，这些进步正在提高患有严重呼吸系统疾病的患者的呼吸照护品质。

慢性呼吸道疾病管理日益受到关注

个人和医疗保健提供者对慢性呼吸道疾病（CRD）管理的日益关注正在促进市场的成长。与此相适应，对更有效率、更有效的 CRD 管理的需求不断增加。除此之外，DDI 可以监测药物依从性并提供可行的回馈，这在更广泛的慢性呼吸道疾病管理策略中发挥着至关重要的作用。此外，它们还使医疗保健提供者能够更好地了解患者的依从性和疾病进展，促进及时干预并为患者带来更好的结果。此外，DDI 的采用不断增加，因为它们促进了更好的自我管理，正在推动市场成长。

本报告回答的关键问题

  • 2023 年全球数位剂量吸入器市场规模有多大？
  • 2024-2032年全球数位剂量吸入器市场的预期成长率是多少？
  • 推动全球数位剂量吸入器市场的关键因素是什么？
  • COVID-19 对全球数位剂量吸入器市场有何影响？
  • 根据类型，全球数位剂量吸入器市场的细分如何？
  • 基于该产品的全球数位剂量吸入器市场的细分情况如何？
  • 全球数位剂量吸入器市场的关键区域有哪些？
  • 全球数位剂量吸入器市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球数位剂量吸入器市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 品牌药物
    • 市场走向
    • 市场预测
  • 仿製药
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依产品

  • 定量吸入器
    • 市场走向
    • 市场预测
  • 干粉吸入器
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • AstraZeneca plc
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • H&T Presspart Manufacturing Ltd.
    • Koninklijke Philips NV
    • Lupin Limited
    • Novartis AG
    • OPKO Health Inc.
    • Propeller Health (ResMed)
    • Sensirion AG Switzerland
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A3986

The global digital dose inhaler market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.7% during 2024-2032. The growing focus on chronic respiratory disease management, technological advancements for real time adjustments, and increasing prevalence of chronic respiratory diseases (CRDs), such as asthma and chronic obstructive pulmonary disease (COPD, are some of the major factors propelling the market.

A digital dose inhaler (DDI) is used for delivering medication to individuals suffering from respiratory ailments like asthma or chronic obstructive pulmonary disease (COPD). It comprises built-in sensors and electronic features that can record when the medication is administered and the quantity of the dose. It assists in ensuring adherence to prescribed treatment routines and allowing for a better understanding of the disease of the patient and the effectiveness of the medication. As it provides feedback to the users and helps them to correct their technique, the demand for DDI is rising across the globe.

At present, the increasing adoption of DDIs, as they offer enhanced convenience and effectiveness in medication delivery, is bolstering the growth of the market. Besides this, the growing demand for efficient and effective inhalation devices among patients is offering a positive market outlook. In line with this, the rising adoption of DDIs among the geriatric population, as they are more prone to respiratory issues, is propelling the market growth. Apart from this, the increasing utilization of DDIs, as they make treatment more transparent and potentially more effective, is contributing to the market growth. Furthermore, the integration of artificial intelligence (AI) in DDIs to enable enhanced monitoring of medication usage and provide real-time feedback to patients is strengthening the market growth. Moreover, the increasing focus on personalized medicines among individuals is supporting the market growth.

Digital Dose Inhaler Market Trends/Drivers:

Increasing prevalence of chronic respiratory diseases

The rising prevalence of chronic respiratory diseases (CRDs), such as asthma and chronic obstructive pulmonary disease (COPD), among the masses worldwide is contributing to the market growth. In addition, there is an increase in the demand for enhanced drug delivery systems among individuals requiring management of their respiratory conditions. Apart from this, DDIs offer a modern solution by ensuring accurate dosage and providing feedback on usage to both patients and healthcare providers, which is offering a positive market outlook. In line with this, the data collected can be instrumental in personalizing treatment plans, improving adherence to medication regimes, and potentially reducing hospitalizations related to CRDs.

Technological advancements for real time adjustments

Various companies are continuously advancing their DDIs to provide enhanced care and satisfaction to patients. They offer features, such as dose counting, adherence monitoring, and data transmission, to healthcare providers. In line with this, these features promote better disease management, allow for real-time adjustments to treatment plans, and ensure that patients are effectively adhering to their medication schedules, which is offering a favorable market outlook. Apart from this, the technology in DDIs can provide immediate feedback to patients on their inhalation technique, which is crucial for the effectiveness of the treatment. As a result, these advancements are enhancing the quality of respiratory care for patients suffering from severe respiratory disorders.

Growing focus on chronic respiratory disease management

The rising focus on chronic respiratory disease (CRD) management among individuals and healthcare providers is contributing to the growth of the market. In line with this, there is an increase in the demand for more efficient and effective management of CRDs. Apart from this, DDIs can monitor medication adherence and provide actionable feedback, which plays a crucial role in the broader strategy of chronic respiratory disease management. In addition, they enable healthcare providers to have better insights into patient adherence and disease progression, facilitating timely interventions and potentially better outcomes for patients. Furthermore, the rising adoption of DDIs, as they promote better self-management, is propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type and product.

Breakup by Type:

Branded Medication

Generics Medication

Branded medication accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes branded medication and generics medication. According to the report, branded medication represented the largest segment. Branded medication refers to drugs that are developed and marketed by pharmaceutical companies under a proprietary name. These medications are often the first of their kind to be introduced to the market and are protected by patents, preventing other companies from selling generic versions for a certain period. The development of branded medications involves thorough research and development (R&D) activities to ensure their efficacy, safety, and quality. Pharmaceutical companies are investing significantly in (R&D) to develop new respiratory medications, which are then sold under a brand name, often at a higher price point due to the innovation and research backing them.

Breakup by Product:

Metered Dose Inhaler

Dry Powder Inhaler

Metered dose inhaler holds the largest share in the industry

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes metered dose inhaler and dry powder inhaler. According to the report, metered dose inhaler accounted for the largest market share. Metered dose inhalers (MDIs) are one of the most common types of inhalers used in respiratory therapy. They are designed to deliver a specific amount of medication to the lungs, with each actuation or press of the inhaler. MDIs consist of a pressurized canister that contains medication in a liquid or aerosol form, housed within a plastic case with a mouthpiece. When the inhaler is actuated, it releases a measured dose of medication in aerosol form for inhalation. MDIs are popular due to their portability, ease of use, and the ability to provide quick relief in acute respiratory situations. They are highly effective for delivering bronchodilators and steroids which are commonly used in the management of conditions like asthma and Chronic Obstructive Pulmonary Disease (COPD).

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest digital dose inhaler market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increasing adoption of advanced respiratory devices. Additionally, the presence of well-established pharmaceutical and medical device companies is offering a positive market outlook. Apart from this, the rising focus on improving respiratory care solutions is contributing to the growth of the market. In addition, increasing incidences of respiratory disorders among individuals are propelling the growth of the market.

Competitive Landscape:

Various companies are investing in research and development (R&D) activities to create DDIs with enhanced features, such as improved dose counting, adherence monitoring, and real-time feedback mechanisms, to cater to the needs of patients and healthcare providers. Apart from this, companies are engaging in collaborations and partnerships to expand their technological capabilities and market reach. In line with this, they are providing more user-friendly and effective solutions for managing respiratory diseases. Besides this, major manufacturers are working on specialized inhaler solutions that are tailored to deliver complex biologics. Furthermore, companies are engaging in marketing and awareness campaigns to educate healthcare providers and patients about the advantages of digital dose inhalers over traditional ones.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

3M Company

AstraZeneca plc

GlaxoSmithKline plc

Glenmark Pharmaceuticals Limited

H&T Presspart Manufacturing Ltd.

Koninklijke Philips N.V.

Lupin Limited

Novartis AG

OPKO Health Inc.

Propeller Health (ResMed)

Sensirion AG Switzerland

Teva Pharmaceutical Industries Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In September 2020, Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd launched two digital maintenance inhalers, such as AirDuo(R) Digihaler(R) (fluticasone propionate and salmeterol) inhalation powder and ArmonAir(R) Digihaler(R) (fluticasone propionate) inhalation powder, for patients with asthma.

In February 2022, AstraZeneca and Honeywell partnered to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has less Global Warming Potential (GWP) than propellants currently used in respiratory medicines.

In July 2023, Lupin launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany.

Key Questions Answered in This Report

  • 1. What was the size of the global digital dose inhaler market in 2023?
  • 2. What is the expected growth rate of the global digital dose inhaler market during 2024-2032?
  • 3. What are the key factors driving the global digital dose inhaler market?
  • 4. What has been the impact of COVID-19 on the global digital dose inhaler market?
  • 5. What is the breakup of the global digital dose inhaler market based on the type?
  • 6. What is the breakup of the global digital dose inhaler market based on the product?
  • 7. What are the key regions in the global digital dose inhaler market?
  • 8. Who are the key players/companies in the global digital dose inhaler market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Dose Inhaler Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Branded Medication
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Generics Medication
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Metered Dose Inhaler
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Dry Powder Inhaler
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 GlaxoSmithKline plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Glenmark Pharmaceuticals Limited
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 H&T Presspart Manufacturing Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Koninklijke Philips N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Lupin Limited
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 OPKO Health Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Propeller Health (ResMed)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Sensirion AG Switzerland
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Teva Pharmaceutical Industries Ltd.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials

List of Figures

  • Figure 1: Global: Digital Dose Inhaler Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Dose Inhaler Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Digital Dose Inhaler Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Digital Dose Inhaler Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Digital Dose Inhaler Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Digital Dose Inhaler Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Digital Dose Inhaler (Branded Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Digital Dose Inhaler (Branded Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Digital Dose Inhaler (Generics Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Digital Dose Inhaler (Generics Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: North America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: North America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: United States: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: United States: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Canada: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Canada: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Asia-Pacific: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Asia-Pacific: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: China: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: China: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Japan: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Japan: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: India: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: India: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: South Korea: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: South Korea: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Australia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Australia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Indonesia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Indonesia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Europe: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Europe: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Germany: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Germany: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: France: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: France: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United Kingdom: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United Kingdom: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Italy: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Italy: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Spain: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Spain: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Russia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Russia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Latin America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Latin America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Brazil: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Brazil: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Mexico: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Mexico: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Middle East and Africa: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Middle East and Africa: Digital Dose Inhaler Market: Breakup by Country (in %), 2023
  • Figure 63: Middle East and Africa: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Global: Digital Dose Inhaler Industry: SWOT Analysis
  • Figure 65: Global: Digital Dose Inhaler Industry: Value Chain Analysis
  • Figure 66: Global: Digital Dose Inhaler Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Dose Inhaler Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Digital Dose Inhaler Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Digital Dose Inhaler Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Digital Dose Inhaler Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Digital Dose Inhaler Market: Competitive Structure
  • Table 6: Global: Digital Dose Inhaler Market: Key Players